Taro Pharmaceutical Industries Ltd.
(NYSE : TARO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan plc
1.96%130.672.8%$449.22m
ZTSZoetis, Inc. Class A
-0.81%113.351.9%$245.52m
TEVATeva Pharmaceutical Industries Limited Sponsored ADR
0.43%8.222.0%$174.95m
MYLMylan N.V.
0.28%18.153.2%$130.34m
JAGXJaguar Animal Health, Inc.
-5.27%4.949.8%$16.95m
TXMDTherapeuticsMD, Inc.
-3.14%2.6324.9%$10.67m
RDYDr. Reddy's Laboratories Ltd. Sponsored ADR
0.62%37.152.0%$6.26m
TAROTaro Pharmaceutical Industries Ltd.
-1.58%87.096.4%$5.93m
ABEOAbeona Therapeutics, Inc.
-1.43%4.827.6%$2.66m
PETXAratana Therapeutics, Inc.
0.20%4.968.5%$1.95m
LFVNLifeVantage Corporation
-3.13%11.773.3%$0.96m
KINKindred Biosciences, Inc.
0.48%8.370.3%$0.80m
CPHIChina Pharma Holdings, Inc.
4.70%0.300.1%$0.11m

Company Profile

Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing, and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada, and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.